title: Beneficial effects of a 5-lipoxygenase inhibitor in endotoxic shock in the rat.
abstract: The effects of a highly selective 5-lipoxygenase inhibitor, CGS8515 [methyl 2-[(3,4-dihydro-3,4-dioxo-1-naphthalenyl) amino]benzoate], on endotoxic shock sequelae and eicosanoid synthesis by peritoneal macrophages were evaluated in the rat. Pretreatment of peritoneal macrophages in vitro with CGS8515 significantly inhibited the synthesis (P less than .01) of immunoreactive leukotriene C4/leukotriene D4 stimulated by the calcium ionophore (A23187). Inhibition of 5-lipoxygenase produced significant shunting to immunoreactive thromboxane B2 formation (P less than .05). In rats sedated with ketamine.HCl (82.5 mg/kg) and xylazine. HCl (27.5 mg/kg), i.v. injection of Salmonella enteritidis endotoxin (25 mg/kg i.v.) produced significant decreases at 30 min in mean arterial pressure (from 89 +/- 4 to 44 +/- 8 mm Hg, N = 5, P less than .001); in white blood cell count (from 10.8 +/- 0.6 to 6.5 +/- 0.8 x 10(3)/mm3, N = 5, P less than .01); in platelet count (from 687 +/- 66 to 392 +/- 65 x 10(3)/mm3, N = 5, P less than .01); and produced an increase of hematocrit (from 46 +/- 1.2 to 57.4 +/- 1.8%, N = 5, P less than .03). CGS8515 (5 mg/kg i.v. 30 min before endotoxin injection, N = 6) blunted the endotoxin-induced hypotension by 35% (P less than .001), the leukopenia by 24% (P less than .03), the thrombocytopenia by 45% (P less than .006) and the hemoconcentration by 16% (P less than .03), compared to the shocked control rats 30 min after endotoxin injection.(ABSTRACT TRUNCATED AT 250 WORDS)
authors.affiliation: Department of Physiology, Medical University of South Carolina, Charleston.
authors.forename: G
authors.initials: G
authors.lastname: Matera
authors.forename: J A
authors.initials: JA
authors.lastname: Cook
authors.forename: R A
authors.initials: RA
authors.lastname: Hennigar
authors.forename: G E
authors.initials: GE
authors.lastname: Tempel
authors.forename: W C
authors.initials: WC
authors.lastname: Wise
authors.forename: T D
authors.initials: TD
authors.lastname: Oglesby
authors.forename: P V
authors.initials: PV
authors.lastname: Halushka
mesh_terms: D000818:Animals; D001091:Arachidonate Lipoxygenases / Q000037:antagonists & inhibitors*; D001794:Blood Pressure / Q000187:drug effects; D006400:Hematocrit; D007970:Leukopenia / Q000209:etiology; D016859:Lipoxygenase Inhibitors; D008297:Male; D009285:Naphthoquinones / Q000494:pharmacology*; D051381:Rats; D012772:Shock, Septic / Q000473:pathology / Q000503:physiopathology*; D013921:Thrombocytopenia / Q000209:etiology; D013929:Thromboxane B2 / Q000096:biosynthesis; D062367:ortho-Aminobenzoates / Q000494:pharmacology*
chemical_list: D016859:Lipoxygenase Inhibitors; D009285:Naphthoquinones; D062367:ortho-Aminobenzoates; C055523:methyl 2-((3,4-dihydro-3,4-dioxo-1-naphthalenyl)amino)benzoate; D013929:Thromboxane B2; D001091:Arachidonate Lipoxygenases